Editas Medicine (EDIT) Other Working Capital Changes (2015 - 2025)
Editas Medicine (EDIT) posted quarterly Other Working Capital Changes of -$1.5 million for Q3 2025, down 606.19% year-over-year from $292972.7 in Q3 2024, and up 69.28% quarter-over-quarter from -$4.8 million in Q2 2025.
Editas Medicine (EDIT) Other Working Capital Changes (2015 - 2025) Analysis & Trends
Editas Medicine (EDIT) has reported Other Working Capital Changes for 9 consecutive years, with -$1.5 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Other Working Capital Changes fell 606.19% year-over-year to -$1.5 million; the TTM figure through Sep 2025 stood at -$20.9 million (down 640.26% YoY), while the FY2024 annual figure was -$8.5 million, down 14.21% from the prior year.
- Other Working Capital Changes rose to -$1.5 million in Q3 2025 per EDIT's latest filing, from -$4.8 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $4.1 million in Q3 2021 and bottomed at -$4.6 million in Q1 2021.
- Historically, Other Working Capital Changes has averaged -$419368.4 across 5 years, with a median of -$160000.0 in 2023.
- On a YoY basis, Other Working Capital Changes climbed as much as 9395.83% in 2024 and fell as far as 641.04% in 2024.
- Editas Medicine's Other Working Capital Changes stood at -$11.3 million in 2021, then soared by 299.81% to $22.6 million in 2022, then sank by 91.5% to $1.9 million in 2023, then sank by 641.04% to -$10.4 million in 2024, then jumped by 85.76% to -$1.5 million in 2025.
- Business Quant data shows EDIT's Other Working Capital Changes at -$1.5 million in Q3 2025, -$4.8 million in Q2 2025, and -$4.2 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Editas Medicine | 263.01 Mn | 116.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -593,000.00 |
| Sep 30, 2025 | -593,000.00 |
| Sep 30, 2025 | -593,000.00 |
| Jun 30, 2025 | 488,000.00 |
| Jun 30, 2025 | 488,000.00 |
| Jun 30, 2025 | 488,000.00 |
| Mar 31, 2025 | -70,000.00 |
| Mar 31, 2025 | -70,000.00 |
| Mar 31, 2025 | -70,000.00 |
| Dec 31, 2024 | -2.79 Mn |
| Dec 31, 2024 | -2.79 Mn |
| Dec 31, 2024 | -2.79 Mn |
| Sep 30, 2024 | -1.07 Mn |
| Sep 30, 2024 | -1.07 Mn |
| Sep 30, 2024 | -1.07 Mn |
| Jun 30, 2024 | -2.14 Mn |
| Jun 30, 2024 | -2.14 Mn |
| Jun 30, 2024 | -2.14 Mn |
| Mar 31, 2024 | 1.61 Mn |
| Mar 31, 2024 | 1.61 Mn |